Compare DMO & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DMO | OPRX |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Business Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.3M | 115.4M |
| IPO Year | 2009 | 2008 |
| Metric | DMO | OPRX |
|---|---|---|
| Price | $11.15 | $6.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.67 |
| AVG Volume (30 Days) | 44.3K | ★ 502.2K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $109,429,000.00 |
| Revenue This Year | N/A | $3.88 |
| Revenue Next Year | N/A | $8.49 |
| P/E Ratio | ★ N/A | $21.96 |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $10.42 | $5.54 |
| 52 Week High | $12.11 | $22.25 |
| Indicator | DMO | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 60.73 | 38.11 |
| Support Level | $11.07 | $5.89 |
| Resistance Level | $11.42 | $7.47 |
| Average True Range (ATR) | 0.18 | 0.48 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 89.04 | 15.30 |
Western Asset Mortgage Defined Opportunity Fund Inc is a non-diversified, limited-term, closed-end management investment company. The fund's primary investment objective is to provide current income. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing in a diverse portfolio of mortgage-backed securities, consisting of non-agency residential mortgage-backed securities and commercial mortgage-backed securities.
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.